← Return to Circulating tumor cells to determine risk of recurrence
DiscussionCirculating tumor cells to determine risk of recurrence
Breast Cancer | Last Active: Sep 20 3:40pm | Replies (41)Comment receiving replies
Replies to "Yes no benefit but "high risk." They have since changed that label because mine was 5.7%..."
I haven't heard of the Prosigna Assay but will write that down. I am at the beginning of my Letrozole journey. My Oncotype was 7%.